OUR DATA
|
Future of Healthcare - Introduction of Clay Christensen Date Released: Apr 2, 2008 |
This presentation briefly introduces the concepts of Clay Christensen who discusses the following:
In the absence of the ability to precisely define a disease, the care of patients is best undertaken by highly
skilled professionals, whose intuition is based on deep experience. This describes the history of health care,
and we call this the practice of intuitive medicine. Molecular cell biology holds the promise of transforming
medical practice into a new phase that we call precision medicine. It promises to dramatically reduce cost
and increase the predictable effectiveness of therapy. [ more info ] |
|
Cell Therapy Market Review Date Released: Apr 1, 2008 |
Cell Therapy promises to prevent, treat, and/or cure human diseases through the administration of ex vivo modified cells. Today, Cell Therapy is already having clinical impact in areas such as cancer and wound treatment where it is being used as the standard of care to treat some diseases. The future of the Cell Therapy market will primarily be driven by the growth of the Stem Cell segment, which itself is triggered by the forthcoming launch of novel therapies for various neurological disorders, cancer, and diabetes applications. The goal of this presentation is to illustrate the current state of Cell Therapy and also to highlight some important unmet needs and key success factors that current and potential market players must address to be successful in this market. [ more info ] |
|
Musculoskeletal Market Strategic Review Date Released: Mar 10, 2008 |
The Musculoskeletal (MSK) market is concerned with the motion and scaffold of the human body (i.e. bones, muscles, tendons, etc.) and is one of many areas of the healthcare industry poised to benefit from the developed world’s increasingly aging population. This presentation highlights the main trends and drivers of the overall MSK market and provides strategic insight into constituent sub-markets. Within the MSK market, we believe the Orthobiologics market is the most attractive segment based on market growth and lower competitive intensity. [ more info ] |
|
Wound Care Market Strategic Review Date Released: Feb 7, 2008 |
The wound care market represents an extremely diverse group of products and therapies, ranging from biological growth factors to wound therapy surfaces such as advanced hospital beds and chairs. For the most part, the wound care market has matured, however, there still remain a variety of high-growth, specialized markets that present good opportunites for investment. This presentation outlines the key drivers and trends of the overall wound care market while also providing insight into emerging trends and technologies that are being rapidly advanced by the industry’s increasing understanding and application of biological processes. [ more info ] |
|
Personalized Medicine Strategic Review Date Released: Dec 19, 2007 |
Personalized medicine tests have had a large impact on the oncology care cycle and greatly influenced therapeutic decisions. Today, as many pharmaceutical companies are plagued by fewer drug approvals and upcoming patent expirations, seeking opportunities within personalized medicine will be one way to bolster sales of therapeutics. We believe oncology therapeutics will continue to be one of the main adopters of personalized medicine and we recommend pharmaceutical companies act accordingly to strategically position themselves within the personalized medicine landscape as well as evaluate any potential influence personalized medicine might have on sales of therapeutics. The goal of this presentation is to review the various types of Molecular Diagnostic based personalized medicine tests and assess their influence on oncology patient care and oncology therapeutics. [ more info ] |
|
In Vitro Diagnostics Strategic Review Date Released: Dec 18, 2007 |
The IVD market is a modest growth market with several segments that show different growth prospects. The overall industry outlook is very positive - driven by favorable demographics, health care cost pressures, industry consolidation, and new high value products. This presentation reviews the IVD industry dynamics, key growth drivers, and market forces such as emergence of rapid clinics that will change the delivery of IVD and patient care. [ more info ] |
|
Molecular Diagnostics Strategic Review Date Released: Dec 17, 2007 |
The purpose of this presentation is to highlight the specific market segment of the in vitro diagnostics market called molecular diagnostics. This presentation includes all the accepted clinical molecular diagnostic tests worlds wide that are currently used today, and explores new tests that are on the clinical horizon. It reviews the instruments and their reagents and supplies as utilized in hospital and commercial labs, clinics, and doctors' offices on a world wide basis.
[ more info ] |
|
Life Science Tools and Technologies Review Date Released: Dec 17, 2007 |
Life Science Tools and Technologies presentation has been assembled by reviewing every major life science/analytical instrument technology and major reagent in the industry. Scientia Advisors regularly reviews market sizing, growth rates, and detailed analyses for this market. [ more info ] |
|
Strategic Review of Point-of-Care Diagnostics Date Released: Jul 5, 2007 |
The purpose of this presentation is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT). It examines these clinical measurement devices and their reagents and supplies as utilized in hospitals, clinics and doctors’ offices. An analysis of analytes that are related to the common chemical constituents of blood, plasma or serum at the point of care of the patient is addressed. Moreover, the presentation defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence the size and the growth of the market segments. Also examined are the subsections of each market segment, including the research labs, hospital labs and commercial laboratories. [ more info ] |
|
Challenges Posed by Combination Medical Products Date Released: Jun 22, 2007 |
The convergence of the biological revolution with medical devices holds the promise of a new stream of innovations. Many medical device companies are grappling with how to manage product innovation and development so as to take advantage of the biological revolution. The goal of this brief presentation is to explore the challenges and opportunities for device companies that this convergence presents. [ more info ] |
|
Better Health Through Functional Foods Date Released: Jun 11, 2007 |
The promise of Functional Foods is improved health outcomes delivered through food that consumers eat on a daily basis. Functional foods are one of the fastest growing areas of the food industry with increasing investment from consumer goods manufacturers, pharmaceutical companies and emerging biotech companies. Scientia's review of the functional foods market provides a definition, overview and forecasts of both the functional food and functional food ingredients market. The review contains comprehensive details on current & emerging features in functional foods including:
[ more info ] |
|
The diabetes circle of care Date Released: May 24, 2007 |
Diabetes is the seventh-leading cause of death, and is on the rise due to increasing obesity in both developed and developing countries. Scientia's review of the diabetes market provides an overview and forecasts of the overall
diabetes care life cycle and discusses the future of the diabetes circle of care. The diabetes circle of care consists of predisposition testing, diagnosis, disease treatment, monitoring, and disease management/lifestyle . This review
does not cover treatment & monitoring of complications associate with diabetes and lifestyle management options associated with the disease. The review contains comprehensive details on current & emerging features in each component of the diabetes care cycle including:
[ more info ] |
